Literature DB >> 6169615

Antiviral treatment of chronic hepatitis B virus infection: improvement in liver disease with interferon and adenine arabinoside.

G H Scullard, L L Andres, H B Greenberg, J L Smith, V K Sawhney, E A Neal, A S Mahal, H Popper, T C Merigan, W S Robinson, P B Gregory.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6169615     DOI： 10.1002/hep.1840010306

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  23 in total

1.  Effects of interferon-alpha therapy on serum and liver HBV DNA in patients with chronic hepatitis B.

Authors:  S V Feinman; B Berris; R Sooknanan; B Fernandes; S Bojarski
Journal:  Dig Dis Sci       Date:  1992-10       Impact factor: 3.199

2.  Laboratory techniques in the diagnosis and assessment of hepatitis B virus infection.

Authors:  J J Gray; T G Wreghitt
Journal:  Genitourin Med       Date:  1992-08

3.  Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.

Authors:  T Okuno; M Shindo; K Arai; M Matsumoto; M Takeda
Journal:  Gastroenterol Jpn       Date:  1990-02

4.  Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection.

Authors:  I V Weller; A S Lok; A Mindel; P Karayiannis; S Galpin; J Monjardino; S Sherlock; H C Thomas
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

Review 5.  What is the actual management of a child with membranous glomerulopathy associated with chronic hepatitis B?

Authors:  M C Chiu
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

6.  Activities of arabinosyladenine monophosphate and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against ground squirrel hepatitis virus in vivo as determined by reduction in serum virion-associated DNA polymerase.

Authors:  D F Smee; S S Knight; A E Duke; W S Robinson; T R Matthews; P L Marion
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

7.  Viral replication in chronic hepatitis B virus infection.

Authors:  B W Trotman
Journal:  Dig Dis Sci       Date:  1983-11       Impact factor: 3.199

8.  Inhibition of salvage pathway enzymes by adenine arabinoside 5'-monophosphate (ara-AMP).

Authors:  H J Becher; P Schollmeyer
Journal:  Klin Wochenschr       Date:  1983-08-01

9.  Psychosocial impact of chronic infection with hepatitis B virus on British patients.

Authors:  A S Lok; D J van Leeuwen; H C Thomas; S Sherlock
Journal:  Genitourin Med       Date:  1985-08

10.  Preliminary trial of recombinant fibroblast interferon in chronic hepatitis B virus infection.

Authors:  M Eisenberg; S Rosno; G Garcia; M W Konrad; P B Gregory; W S Robinson; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.